Many people infected with the hepatitis C virus are not cured despite gruelling therapy. A human genetic variant that predicts successful treatment has been identified. So is personalized therapy now a possibility?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ge, D. et al. Nature 461, 399–401 (2009).
Suppiah, V. et al. Nature Genet. doi:10.1038/ng.447 (2009). | Article |
Tanaka, Y. et al. Nature Genet. doi:10.1038/ng.449 (2009). | Article |
McHutchison, J. G. et al. N. Engl. J. Med. 361, 580–593 (2009).
Sheppard, P. et al. Nature Immunol. 4, 63–68 (2003).
Thomas, D. L. et al. Nature doi:10.1038/nature08463 (2009). | Article |
Shiffman, M. L. et al. Proc. 44th Annu. Meet. Eur. Assoc. Study Liver (EASL), Copenhagen, abstr. 520 (2009).
The International HapMap Consortium Nature 437, 1299–1320 (2005).
Conjeevaram, H. S. et al. Gastroenterology 131, 470–477 (2006).
Riordan, J. R. et al. Science 245, 1066–1073 (1989).
Fatkenheuer, G. et al. Nature Med. 11, 1170–1172 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iadonato, S., Katze, M. Hepatitis C virus gets personal. Nature 461, 357–358 (2009). https://doi.org/10.1038/461357a
Published:
Issue Date:
DOI: https://doi.org/10.1038/461357a
This article is cited by
-
Genome-wide association studies in pharmacogenomics
Nature Reviews Genetics (2010)